Viewing Study NCT04636008


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-01-31 @ 6:41 AM
Study NCT ID: NCT04636008
Status: RECRUITING
Last Update Posted: 2024-08-06
First Post: 2020-11-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Sponsor: West China Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anti-PD-1 Antibody View
None Radiotherapy View
None Rectal Cancer View
None MSI-H View
None Mmr Deficiency View
Keywords: